Neogen Corporation (NEOG) Fair Value 2026

NEOG · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.9 /10

32 fundamental signals · 7 models active

Value Trap Risk

LOW (27/100)

Quick Summary — As of 2026-08-27, Neogen Corporation (NEOG) trades at $11.74, versus a $6.73 median fair value across its 7 active models — 42.6% below the current price. QOC: 6.9/10. Value Trap Risk: 27/100 (LOW). 7/13 models active.

Key Facts

Ticker
NEOG
Price
$11.74
Quality Score
6.9/10
Value Trap Risk
27/100
Models Active
7/13
Last Updated
Strength: 7 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Neogen Corporation (NEOG) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, Neogen Corporation (NEOG) appears overvalued as of : the median of 7 independent fair value estimates is $6.73, 42.6% below the current price of $11.74. Estimates range from $1.83 to $12.75. NEOG scores 6.9/10 on fundamental quality and 27/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. NEOG’s -42.6% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Neogen Corporation Stock in 2026? →

What Fair Value Does Each Model Give NEOG?

7 Intrinsic Value Models vs. Current Price ($11.74)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $6.73 -42.6%
Scenario · High Conviction
 $6.11 -47.9%
Intrinsic · High Conviction
 $1.83 -84.4%
Unlock the Full Matrix

Access 4 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is NEOG's Fair Value Range?

Spread across 7 independent models · $1.83 to $12.75

CirclFi's 7 active models place Neogen Corporation (NEOG) between $1.83 and $12.75 per share, a spread of 162% of the median. The median of that range — $6.73 — is the fair value CirclFi publishes for NEOG, against a current price of $11.74.

Low · ML-RIVHigh · PWERM
$1.83median $6.73$12.75
Where the range comes from
Most bearish modelML Residual Income$1.83
Most bullish modelPWERM$12.75
Model agreement1 bullish · 5 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for NEOG. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on NEOG, not a CirclFi price target. How each model works →

What Is Neogen Corporation (NEOG) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Neogen Corporation at its current price of $11.74. The median intrinsic value is estimated at $6.73 (-42.6% vs price), with 5 models flagging overvaluation risk. The most optimistic model, PWERM, places fair value at $12.75 (+8.6%), while ML-RIV — the most conservative — estimates $1.83 (-84.4%). This +93.0% gap reflects genuine analytical uncertainty about Neogen Corporation's intrinsic worth.

What Do the Models Say About NEOG?

7 of 13 models are currently active for NEOG. Of these, 1 model suggests upside while 6 models suggest overvaluation. Taken together, their median fair value for NEOG is $6.73 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does NEOG Rank in Medical Devices?

Among 157 Medical Devices stocks, NEOG ranks #56 by Quality of Company score. CirclFi's QOC score of 6.9/10 evaluates 32 fundamental signals. A score of 6.9 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

As a pharmaceutical industry, Neogen Corporation operates in a sector where patent cliff exposure is a critical driver of valuation. Investors evaluating NEOG should weigh these sector-specific dynamics alongside our model-derived fair values.

Is NEOG a Value Trap?

CirclFi's Value Trap algorithm assigns NEOG a score of 27/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for Neogen Corporation. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Neogen Corporation's fundamental quality profile registers 6.9/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +93.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NEOG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NEOG's 7 active models, average confidence is 41%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Neogen Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ATECAlphatec Holdings, Inc.QOC 6.9SENSSenseonics Holdings, Inc.QOC 6.8ARAYAccuray IncorporatedQOC 6.9HYPRHyperfine, Inc.QOC 6.8CTKBCytek Biosciences, Inc.QOC 6.9PROFProfound Medical Corp.QOC 6.8OWLTOwlet, Inc.QOC 5.8CSDXCS Diagnostics Corp.QOC 4.5SNNSmith & Nephew plcQOC 8.7IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ATEC · SENS · ARAY · HYPR · CTKB · PROF · OWLT · CSDX · SNN · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to NEOG?

7 companies across all industries closest to NEOG’s Quality of Company score of 6.9/10.

MIAXMiami International Holdings, Inc.QOC 6.9CCSCentury Communities, Inc.QOC 6.9CGAUCenterra Gold Inc.QOC 6.9DRVNDriven Brands Holdings Inc.QOC 6.9NLNLI Holdings, Inc.QOC 6.9SOFISoFi Technologies, Inc.QOC 6.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MIAX · CCS · CGAU · DRVN · NL · SOFI · NVDA

Where Does NEOG Sit in CirclFi's Medical Devices Rankings?

NEOG is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Neogen Corporation’s Valuation?

What is Neogen Corporation's intrinsic value in 2026?

CirclFi puts Neogen Corporation (NEOG)'s intrinsic value at $6.73 — the median of 7 independent model estimates as of 2026-08-27, ranging from $1.83 to $12.75. The Quality of Company score is 6.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NEOG overvalued or undervalued right now?

At $11.74, 1 of 7 active models suggest NEOG may be undervalued, while 6 indicate potential overvaluation. The median of all 7 fair value estimates is $6.73, 42.6% below the current price of $11.74 — a consensus view that NEOG is overvalued. The assessment depends on which methodology best fits Neogen Corporation's business model in Medical Devices.

What does a Quality of Company score of 6.9 mean for NEOG?

Neogen Corporation's QOC of 6.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on NEOG?

CirclFi analyzes NEOG with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on NEOG?

Of the 7 models currently active on NEOG, PWERM is the most bullish at $12.75 per share, and ML Residual Income is the most bearish at $1.83. CirclFi's published fair value for NEOG is the median of that range, $6.73, not either extreme. The gap between the two ends equals 162% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is NEOG a value trap in 2026?

Neogen Corporation's Value Trap score is 27/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 7-model valuation engine, Neogen Corporation (NEOG) has a median fair value of $6.73 — 42.6% below the current price of $11.74 — as of 2026-08-27.” Source: circlfi.com/stock/NEOG/ · Methodology
Primary sources for this NEOG valuation
  • Financial statements: Neogen Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0000711377) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for NEOG as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on NEOG.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for NEOG Unlock All 7 — $39/mo